The global Nanobody Discovery Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

Nanobody discovery service is a nanobody-based technology for screening and discovering nanobodies with high affinity and specificity. Nanobodies are natural single-chain antibodies that exist in the serum of camelids and sharks. Compared with traditional antibodies, nanobodies have the advantages of small molecular weight, good stability, and strong tissue penetration ability. Because they have no light chain structure, they can be flexibly combined with various antibody molecules. They are used in bispecific antibody drugs and cell therapy drugs. It has broad application prospects in the field of disease diagnosis and treatment, such as diagnosis and detection.

Market Overview:

• United States market for Nanobody Discovery Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
• China market for Nanobody Discovery Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
• Europe market for Nanobody Discovery Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Key features:

• Global key Nanobody Discovery Service players cover Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Segmentation by Type:

1. Screening and Development Services
2. Engineering and Optimization Services
3. Production and Expression Services
4. Other Services

Segmentation by Application:

1. Drug Discovery
2. Biological Engineering
3. Clinical Diagnosis
4. Immune Research
5. Others

Market by Region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Company's Coverage:

• Creative Biolabs
• Curia
• Sanofi
• NanoTag Biotechnologies
• Shanghai Medicilon Inc.
• Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
• Yeasen Biotechnology（Shanghai）Co.,Ltd.
• Fortis Life Sciences
• Biointron Biological Inc.
• SAFE Pharmaceutical Technology Co., Ltd.
• Abterra Biosciences
• Chengdu Apak Biotechnology Co., Ltd.
• ICarTab Biomedical Co., Ltd.
• Wuhan Daian Biotech Ltd

Key Questions Addressed in this Report: